RA CAPITAL MANAGEMENT, L.P.
Related Filers (259)
- Kolchinsky Peter (313)
- RA Capital Healthcare Fund LP (294)
- Shah Rajeev M. (187)
- RA Capital Nexus Fund II, L.P. (53)
- RA Capital Healthcare Fund II, L.P. (42)
- ALDRICH RICHARD (36)
- ACHILLION PHARMACEUTICALS INC (36)
- RA Capital Nexus Fund, L.P. (30)
- BIOSPECIFICS TECHNOLOGIES CORP (26)
- 89bio, Inc. (21)
- SEQUENOM INC (18)
- Wave Life Sciences Ltd. (17)
- Aclaris Therapeutics, Inc. (17)
- SANGAMO BIOSCIENCES INC (16)
- Ascendis Pharma A/S (16)
- Solid Biosciences Inc. (16)
- Kala Pharmaceuticals, Inc. (15)
- Dicerna Pharmaceuticals Inc (13)
- DERMA SCIENCES, INC. (13)
- Cytek Biosciences, Inc. (13)
- ARADIGM CORP (12)
- Ra Pharmaceuticals, Inc. (12)
- KalVista Pharmaceuticals, Inc. (12)
- TG THERAPEUTICS, INC. (12)
- DICE Therapeutics, Inc. (12)
- BIOCRYST PHARMACEUTICALS INC (11)
- scPharmaceuticals Inc. (11)
- Orchard Therapeutics plc (11)
- Werewolf Therapeutics, Inc. (11)
- Enliven Therapeutics, Inc. (11)
- Satsuma Pharmaceuticals, Inc. (11)
- ZOGENIX, INC. (10)
- RHYTHM PHARMACEUTICALS, INC. (10)
- Phathom Pharmaceuticals, Inc. (10)
- Vor Biopharma Inc. (10)
- AN2 Therapeutics, Inc. (10)
- Forma Therapeutics Holdings, Inc. (9)
- ARS Pharmaceuticals, Inc. (9)
- PepGen Inc. (9)
- Fulcrum Therapeutics, Inc. (9)
- CURIS INC (8)
- Nkarta, Inc. (8)
- Vaxcyte, Inc. (8)
- POINT Biopharma Global Inc. (8)
- Eliem Therapeutics, Inc. (8)
- Acumen Pharmaceuticals, Inc. (8)
- ARDELYX, INC. (8)
- LIPID SCIENCES INC/ (7)
- ACADIA PHARMACEUTICALS INC (7)
- EyePoint Pharmaceuticals, Inc. (7)
- Inhibrx, Inc. (7)
- Icosavax, Inc. (7)
- Tyra Biosciences, Inc. (7)
- ARCA biopharma, Inc. (6)
- DYAX CORP (6)
- NOVAVAX INC (6)
- TENAX THERAPEUTICS, INC. (6)
- PROTEON THERAPEUTICS INC (6)
- SUNESIS PHARMACEUTICALS INC (6)
- Verastem, Inc. (6)
- Janux Therapeutics, Inc. (6)
- Aerovate Therapeutics, Inc. (6)
- Mineralys Therapeutics, Inc. (6)
- GENELABS TECHNOLOGIES INC /CA (5)
- Northstar Neuroscience, Inc. (5)
- Vanda Pharmaceuticals Inc. (5)
- TENGION INC (5)
- Regulus Therapeutics Inc. (5)
- AQUINOX PHARMACEUTICALS, INC (5)
- ARVINAS, INC. (5)
- Synthorx, Inc. (5)
- InflaRx N.V. (5)
- Travere Therapeutics, Inc. (5)
- Iterum Therapeutics plc (5)
- ChemoCentryx, Inc. (5)
- Akouos, Inc. (5)
- iTeos Therapeutics, Inc. (5)
- Connect Biopharma Holdings Ltd (5)
- Dyne Therapeutics, Inc. (5)
- GH Research PLC (5)
- Acrivon Therapeutics, Inc. (5)
- MACROGENICS INC (5)
- Chelsea Therapeutics International, Ltd. (4)
- VENTRUS BIOSCIENCES INC (4)
- ONCOGENEX PHARMACEUTICALS, INC. (4)
- ARROWHEAD RESEARCH CORP (4)
- SANUWAVE Health, Inc. (4)
- DYNAVAX TECHNOLOGIES CORP (4)
- Zynerba Pharmaceuticals, Inc. (4)
- Cidara Therapeutics, Inc. (4)
- ENDOCYTE INC (4)
- Strongbridge Biopharma plc (4)
- Eidos Therapeutics, Inc. (4)
- Viridian Therapeutics, Inc.\DE (4)
- RELMADA THERAPEUTICS, INC. (4)
- Pandion Therapeutics, Inc. (4)
- Astria Therapeutics, Inc. (4)
- Inozyme Pharma, Inc. (4)
- Olema Pharmaceuticals, Inc. (4)
- Achilles Therapeutics plc (4)
- Show More ...
Other (70)
13F-HR
Wednesday, 2/14/2024
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Wednesday, 11/15/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/15/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 2/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/15/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/16/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/17/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/16/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/16/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/14/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/15/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 2/14/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 11/14/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 8/14/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 5/15/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 2/14/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 11/14/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 8/14/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 5/15/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 2/14/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/14/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/14/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/15/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Thursday, 2/16/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Thursday, 2/16/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/16/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 11/13/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 8/13/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Monday, 7/6/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/15/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/17/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 11/14/2014
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 8/14/2014
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 5/15/2014
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 2/14/2014
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 11/14/2013
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 8/14/2013
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 5/15/2013
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 2/14/2013
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 11/14/2012
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 8/14/2012
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 5/15/2012
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2012
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2011
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2011
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2011
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 2/14/2011
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 11/12/2010
Initial Quarterly Form 13F Holdings Report filed by institutional managers
CORRESP
Friday, 10/15/2010
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
13F-HR
Monday, 8/16/2010
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/14/2010
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/16/2010
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/16/2009
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 8/13/2009
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/15/2009
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/17/2009
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 11/14/2008
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 8/13/2008
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 5/14/2008
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 2/14/2008
Initial Quarterly Form 13F Holdings Report filed by institutional managers
Ownership (1124)
SC 13G/A
Wednesday, 2/14/2024
HilleVax, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
RHYTHM PHARMACEUTICALS, INC.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
GERON CORP: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
EyePoint Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
NEKTAR THERAPEUTICS: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Inhibrx, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Verona Pharma plc: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Vaxcyte, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Gracell Biotechnologies Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Aclaris Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
ALPINE IMMUNE SCIENCES, INC.: Major Shareholders
SC 13D/A
Wednesday, 2/14/2024
Werewolf Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
4D Molecular Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Taysha Gene Therapies, Inc.: Major Shareholders
4
Wednesday, 2/14/2024
Mineralys Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Wednesday, 2/14/2024
Ascendis Pharma A/S: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
RxSight, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Cogent Biosciences, Inc.: Major Shareholders
SC 13G
Wednesday, 2/14/2024
Apogee Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
NewAmsterdam Pharma Co N.V.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Harpoon Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
NanoString Technologies Inc: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Fulcrum Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
UroGen Pharma Ltd.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Celcuity Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Tourmaline Bio, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
CureVac N.V.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
AN2 Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Unicycive Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Avidity Biosciences, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
MACROGENICS INC: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Tenaya Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Day One Biopharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Orchard Therapeutics plc: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
ImmunoGen, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
GH Research PLC: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
CHIMERIX INC: Major Shareholders
4
Tuesday, 2/13/2024
PepGen Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 2/13/2024
PepGen Inc.: Major Shareholders
SC 13G
Monday, 2/12/2024
Astria Therapeutics, Inc.: Major Shareholders
SC 13G
Monday, 2/12/2024
Corbus Pharmaceuticals Holdings, Inc.: Major Shareholders
SC 13D/A
Monday, 2/12/2024
Mineralys Therapeutics, Inc.: Major Shareholders
4
Thursday, 2/8/2024
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 2/6/2024
Tyra Biosciences, Inc.: Major Shareholders
SC 13G
Monday, 2/5/2024
Adicet Bio, Inc.: Major Shareholders
SC 13G
Friday, 2/2/2024
Dianthus Therapeutics, Inc. /DE/: Major Shareholders
SC 13G
Monday, 1/29/2024
Edgewise Therapeutics, Inc.: Major Shareholders
SC 13G
Friday, 1/19/2024
Vaxart, Inc.: Major Shareholders
4/A
Wednesday, 1/17/2024
Wave Life Sciences Ltd.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 1/12/2024
Longboard Pharmaceuticals, Inc.: Major Shareholders
4
Friday, 1/12/2024
Solid Biosciences Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 1/11/2024
Solid Biosciences Inc.: Major Shareholders
SC 13G
Friday, 12/29/2023
UroGen Pharma Ltd.: Major Shareholders
SC 13G
Tuesday, 12/26/2023
C4 Therapeutics, Inc.: Major Shareholders
SC 13D/A
Wednesday, 12/20/2023
Connect Biopharma Holdings Ltd: Major Shareholders
SC 13D/A
Thursday, 12/14/2023
Connect Biopharma Holdings Ltd: Major Shareholders
4
Wednesday, 12/13/2023
89bio, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/13/2023
Wave Life Sciences Ltd.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 12/13/2023
89bio, Inc.: Major Shareholders
SC 13D/A
Monday, 12/4/2023
Connect Biopharma Holdings Ltd: Major Shareholders
SC 13G
Monday, 11/27/2023
Third Harmonic Bio, Inc.: Major Shareholders
SC 13D/A
Friday, 11/17/2023
Eliem Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 11/14/2023
Design Therapeutics, Inc.: Major Shareholders
SC 13G
Monday, 11/6/2023
Harpoon Therapeutics, Inc.: Major Shareholders
SC 13G
Monday, 10/30/2023
MACROGENICS INC: Major Shareholders
SC 13G
Thursday, 10/5/2023
SOLENO THERAPEUTICS INC: Major Shareholders
SC 13G
Friday, 9/29/2023
CHIMERIX INC: Major Shareholders
4
Monday, 9/25/2023
ARS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 9/25/2023
ARS Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Friday, 9/22/2023
CymaBay Therapeutics, Inc.: Major Shareholders
SC 13D/A
Tuesday, 9/19/2023
Cytek Biosciences, Inc.: Major Shareholders
4
Thursday, 8/31/2023
ARS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Thursday, 8/31/2023
ARS Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Friday, 8/25/2023
Taysha Gene Therapies, Inc.: Major Shareholders
4
Tuesday, 8/22/2023
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 8/21/2023
Gracell Biotechnologies Inc.: Major Shareholders
SC 13G
Thursday, 8/17/2023
NEKTAR THERAPEUTICS: Major Shareholders
SC 13G/A
Monday, 8/14/2023
Kinnate Biopharma Inc.: Major Shareholders
SC 13G/A
Monday, 8/14/2023
BELLUS Health Inc.: Major Shareholders
SC 13D/A
Friday, 8/11/2023
Vor Biopharma Inc.: Major Shareholders
SC 13D/A
Friday, 8/11/2023
89bio, Inc.: Major Shareholders
4
Wednesday, 8/9/2023
DICE Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 8/9/2023
DICE Therapeutics, Inc.: Major Shareholders
4
Wednesday, 8/9/2023
Wave Life Sciences Ltd.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 8/1/2023
NewAmsterdam Pharma Co N.V.: Major Shareholders
4
Tuesday, 7/25/2023
Acumen Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 7/25/2023
Acumen Pharmaceuticals, Inc.: Major Shareholders
4
Friday, 7/21/2023
Janux Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/7/2023
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 7/6/2023
Talaris Therapeutics, Inc.: Major Shareholders
SC 13G
Thursday, 7/6/2023
Unicycive Therapeutics, Inc.: Major Shareholders
4
Wednesday, 6/28/2023
ARS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 6/27/2023
Aerovate Therapeutics, Inc.: Major Shareholders
4
Friday, 6/23/2023
Werewolf Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 6/21/2023
DICE Therapeutics, Inc.: Major Shareholders
4
Friday, 6/16/2023
Janux Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
Acumen Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/12/2023
Satsuma Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 6/12/2023
Satsuma Pharmaceuticals, Inc.: Major Shareholders
4
Friday, 6/9/2023
Nkarta, Inc.: Statement of changes in beneficial ownership of securities
Proxies (3)
DFAN14A
Monday, 9/13/2010
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Tuesday, 12/16/2008
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
PREN14A
Monday, 12/15/2008
Preliminary proxy statement filed by non-management